Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset, specifically chronic debilitating diarrhea. The company is headquartered in San Francisco, California. Show more

200 PINE STREET, SAN FRANCISCO, CA, UNITED STATES, 94104, San Francisco, CA, 94104, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

3.847M

52 Wk Range

$0.72 - $85.40

Previous Close

$0.76

Open

$0.78

Volume

108,244

Day Range

$0.74 - $0.81

Enterprise Value

40.6M

Cash

7.278M

Avg Qtr Burn

N/A

Insider Ownership

8.58%

Institutional Own.

0.11%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Canalevia (crofelemer) Details Noninfectious diarrhea	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Crofelemer powder Details Microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF)	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Mytesi® (crofelemer) Details Cancer therapy-related diarrhea (CTD)	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.